Definitive Healthcare reported Q4 2024 revenue of $62.3 million, a 6% decrease from Q4 2023. The company experienced a net loss of $(84.7) million, significantly impacted by goodwill impairment charges of $97.1 million. Despite the net loss, adjusted net income increased to $12.6 million and adjusted EBITDA was $17.5 million, representing 28% of revenue.
Q4 2024 revenue was $62.3 million, a 6% decrease year-over-year.
Net loss for Q4 2024 was $(84.7) million, primarily due to $97.1 million in goodwill impairment charges.
Adjusted Net Income for Q4 2024 increased to $12.6 million from $10.6 million in Q4 2023.
Adjusted EBITDA for Q4 2024 was $17.5 million, representing 28% of revenue.
For the first quarter of 2025, Definitive Healthcare expects revenue between $55.5 million and $57.0 million, adjusted operating income between $7.5 million and $8.5 million, and adjusted EBITDA between $10.5 million and $11.5 million. For the full year 2025, revenue is projected to be between $230.0 million and $240.0 million, with adjusted EBITDA between $61.0 million and $65.0 million.
Analyze how earnings announcements historically affect stock price performance